These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14566258)

  • 41. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.
    Wardlaw SA; March TH; Belinsky SA
    Carcinogenesis; 2000 Jul; 21(7):1371-7. PubMed ID: 10874016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
    Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ
    Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
    Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
    Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
    Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma.
    Gendy AS; Lipskar A; Glick RD; Steinberg BM; Edelman M; Soffer SZ
    J Pediatr Surg; 2011 Jan; 46(1):108-14. PubMed ID: 21238650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.
    Drachman DB; Frank K; Dykes-Hoberg M; Teismann P; Almer G; Przedborski S; Rothstein JD
    Ann Neurol; 2002 Dec; 52(6):771-8. PubMed ID: 12447931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Palmer RH
    JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Fernandez H; Lesser GT
    JAMA; 2000 Apr; 283(15):1961; author reply 1962. PubMed ID: 10789661
    [No Abstract]   [Full Text] [Related]  

  • 51. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
    Bresalier RS
    Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
    [No Abstract]   [Full Text] [Related]  

  • 53. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
    Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
    Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.
    Muscará MN; Vergnolle N; Lovren F; Triggle CR; Elliott SN; Asfaha S; Wallace JL
    Br J Pharmacol; 2000 Apr; 129(7):1423-30. PubMed ID: 10742298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
    Dickens DS; Cripe TP
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):709-14. PubMed ID: 12972806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal effects on a solitary kidney of specific inhibition of cyclooxygenease-2 after 24 h of complete ureteric obstruction in rats.
    Oztürk H; Ozdemir E; Otcu S; Büyükbayram H; Ihsan Dokucu A
    Urol Res; 2002 Sep; 30(4):223-6. PubMed ID: 12202939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
    Clin Cancer Res; 2004 Sep; 10(17):5930-9. PubMed ID: 15355926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL; McKnight W; Reuter BK; Vergnolle N
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of Celecoxib on inflammation and synovial microcirculation in murine antigen-induced arthritis.
    Gebhard HH; Zysk SP; Schmitt-Sody M; Jansson V; Messmer K; Veihelmann A
    Clin Exp Rheumatol; 2005; 23(1):63-70. PubMed ID: 15789889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.